Justin Leong - 22 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
President, Asia Latin America
Signature
Justin Leong, President Asia and Latin America
Issuer symbol
RMD
Transactions as of
22 Nov 2022
Transactions value $
-$420
Form type
4
Filing time
23 Nov 2022, 15:42:19 UTC
Previous filing
18 Nov 2022
Next filing
06 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ReMed Common Stock Options Exercise $866K +15K +30.87% $57.76 63.6K 22 Nov 2022 Direct
transaction RMD ReMed Common Stock Sale -$867K -3.78K -5.94% $229.50 59.8K 22 Nov 2022 Direct F1
transaction RMD ReMed Common Stock Award $0 +6.92K +11.58% $0.00 66.7K 23 Nov 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -15K -100% $0.00* 0 22 Nov 2022 ResMed Common Stock 15K $57.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $229.42 $229.56. The price reported above reflects the weighted average sale price.
F2 Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.